blinded dexcom g6 cgm (Dexcom Inc)
90
Structured Review
Dexcom Inc
blinded dexcom g6 cgm
Blinded Dexcom G6 Cgm, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blinded+dexcom+g6+cgm/dexcom+g6/pmc10882371__bmjopen___2023___078171__draft_revisions-224-165-225
Average 90 stars, based on 1 article reviews
Blinded Dexcom G6 Cgm, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blinded+dexcom+g6+cgm/dexcom+g6/pmc10882371__bmjopen___2023___078171__draft_revisions-224-165-225
Average 90 stars, based on 1 article reviews
blinded dexcom g6 cgm - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Continuous and Intermittent Glucose Monitoring in 2022. Article Snippet: Our societies are slowly and cautiously returning to normality, leaving the pandemic turmoil behind us and affording us some more time to focus on the evaluation of the recent telemedicine experiences in diabetes.. Many lessons were learned quicker than anticipated under normal circumstances; however, several questions remained unanswered, and some new uncertainties appeared.. Continuous glucose monitoring (CGM) clearly took a central position in diabetes management, particularly in tertiary diabetes centers. Article Title: Study protocol for a randomised open label clinical trial examining the safety and efficacy of the Android Artificial Pancreas System (AAPS) with advanced bolus-free features in adults with type 1 diabetes: the ‘CLOSE IT’ (Closed Loop Open SourcE In Type 1 diabetes) trial Article Snippet: Table 2: Baseline assessments Demographic Ethnicity Gender Highest level of education attained Auxological Height Weight Body mass index Diabetic Prior or current use of CGM or flash glucose monitoring (>75% use) Number of episodes of severe hypoglycaemia in the 12 months prior to baseline visit Page 18 of 33 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml BMJ Open 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 For peer review only Number of episodes of diabetic ketoacidosis in the 12 months prior to baseline visit Mean total daily dose (TDD) of insulin over the previous 14 days Mode of Article Title: Abstracts of the 2024 Pediatric Endocrine Society (PES) Annual Meeting. Chicago, IL, May 2 - 5, 2024. Article Snippet: 6584 LOWER EXECUTIVE FUNCTIONING AND FINE MOTOR DEXTERITY IN CONGENITAL ADRENAL HYPERPLASIA ASSOCIATED WITH Article Title: Continuous Glucose Monitoring-Guided Insulin Administration in Hospitalized Patients With Diabetes: A Randomized Clinical Trial. Article Snippet: Subjects were randomly assigned (1:1 ratio) to one of two groups: a standard of care with participants wearing a blinded Article Title: Personalized glucose forecasting for people with type 1 diabetes using large language models. Article Snippet: CGM data were obtained using either Article Title: A Pilot Study of the Feasibility and Accuracy of Inpatient Continuous Glucose Monitoring. Article Snippet: This study used a blinded Article Title: Dynamic Methods for Childhood Hypoglycemia Phenotyping: A Narrative Review Article Snippet: Shah et al. recently reported CGM profiles from 153 nonpregnant, healthy, nondiabetic children and adults (age ≥6 years) with nonobese body mass index, using a blinded Article Title: Study protocol for a randomised open label clinical trial examining the safety and efficacy of the Android Artificial Pancreas System (AAPS) with advanced bolus-free features in adults with type 1 diabetes: the ‘CLOSE IT’ (Closed Loop Open SourcE In Type 1 diabetes) trial Article Snippet: Table 1: Baseline assessments Demographic Ethnicity Gender Highest level of education attained Auxological Height Weight Body mass index Diabetic Prior or current use of CGM or flash glucose monitoring (>75% use) Number of episodes of severe hypoglycaemia in the 12 months prior to baseline visit Number of episodes of diabetic ketoacidosis in the 12 months prior to baseline visit Mean total daily dose (TDD) of insulin over the previous 14 days Mode of insulin delivery (i.e. multiple daily injections or insulin pump) Clinical examination for lipohypertrophy that may impair absorption of subcutaneous insulin Laboratory Venous blood sample obtained for HbA1c, full blood count, and serum creatinine Clinical Known allergies Page 17 of 35 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml BMJ Open 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 For peer review only Concomitant medications Adverse event check Diet Assessment of current carbohydrate intake, recorded over a three-day period Psychosocial EuroQol 5-dimensional Questionnaire 5-Level (EQ-5D-5L) Insulin Dosing Systems: Perceptions, Ideas, Reflections, and Expectations (INSPIRE) (pre-intervention questionnaire) Blinded |